Empathy — Exploring the Effectiveness the Attitude, Competence of Care, Empathy Among the Home Care Workers With Dementia People
Citation(s)
Dyer E, Swartzlander BJ, Gugliucci MR Using virtual reality in medical education to teach empathy. J Med Libr Assoc. 2018 Oct;106(4):498-500. doi: 10.5195/jmla.2018.518. Epub 2018 Oct 1.
Jütten LH, Mark RE, Maria Janssen BWJ, Rietsema J, Dröes RM, Sitskoorn MM Testing the effectivity of the mixed virtual reality training Into D'mentia for informal caregivers of people with dementia: protocol for a longitudinal, quasi-experimental study. BMJ Open. 2017 Aug 21;7(8):e015702. doi: 10.1136/bmjopen-2016-015702.
Jütten LH, Mark RE, Sitskoorn MM Can the Mixed Virtual Reality Simulator Into D'mentia Enhance Empathy and Understanding and Decrease Burden in Informal Dementia Caregivers? Dement Geriatr Cogn Dis Extra. 2018 Dec 6;8(3):453-466. doi: 10.1159/000494660. eCollection 2018 Sep-Dec.
Kim D Development and Effect of Virtual Reality Practice Program for Improving Practical Competency of Caregivers Specializing in Dementia. Healthcare (Basel). 2021 Oct 18;9(10). pii: 1390. doi: 10.3390/healthcare9101390.
Pollock M, Hornabrook RW The prevalence, natural history and dementia of Parkinson's disease. Brain. 1966 Sep;89(3):429-48.
Shin D Empathy and embodied experience in virtual environment: To what extent can virtual reality stimulate empathy and embodied experience? Comput Hum Behav. 2018;78:64-73. doi:10.1016/j.chb.2017.09.012
Wijma EM, Veerbeek MA, Prins M, Pot AM, Willemse BM A virtual reality intervention to improve the understanding and empathy for people with dementia in informal caregivers: results of a pilot study. Aging Ment Health. 2018 Sep;22(9):1115-1123. doi: 10.1080/13607863.2017.1348470. Epub 2017 Jul 10.
Discussion on Virtual Reality Intervention Course: Exploring the Effectiveness of the Attitude of Care
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
